Buscar
Mostrando ítems 1-10 de 79
Optimizing iron delivery in the management of anemia: Patient considerations and the role of ferric carboxymaltose
(Dove Medical Press Ltd., 2014-12)
With the challenge of optimizing iron delivery, new intravenous (iv) iron-carbohydrate complexes have been developed in the last few years. A good example of these new compounds is ferric carboxymaltose (FCM), which has ...
Silicon Increases Leaf Chlorophyll Content and Iron Nutritional Efficiency and Reduces Iron Deficiency in Sorghum Plants
(2020-09-01)
The objective of this study was to evaluate the effect of silicon (Si) on iron (Fe) deficiency in sorghum plants grown in a nutrient solution, seeing that sorghum crops are sensitive to iron deficiency and Si may alleviate ...
The Induction of Oxidative/Nitrosative Stress, Inflammation, and Apoptosis by a Ferric Carboxymaltose Copy Compared to Iron Sucrose in a Non-Clinical Model
(Premchand Shantidevi Research Foundation, 2015-12)
Introduction: Ferric carboxymaltose is a next-generation polynuclear iron(III)-hydroxide carbohydrate complex for intravenous iron therapy belonging to the class of so-called non-biological complex drugs. The product ...
IRON CONCENTRATIONS IN SUGAR CANE (Saccharum officinarum L.) CULTIVATED IN NUTRIENT SOLUTION
(Colegio Postgraduados, 2016-10-01)
Doubts remain about the adequate iron (Fe) concentration in nutrient solutions used for optimal plant growth, especially in gramineae like sugar cane (Saccharum officinarum L.). Therefore, the aim of this study was to ...
Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status
(Public Library of Science, 2015-04)
BACKGROUND: Patients with non-dialysis-dependent chronic kidney disease (ND-CKD) often receive an erythropoiesis-stimulating agent (ESA) and oral iron treatment. This study evaluated whether a switch from oral iron to ...
Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound
(Dove Medical Press Ltd., 2017-11)
Background: Ferric carboxymaltose (FCM) is a stable, non-dextran-based intravenous iron complex used to treat iron deficiency of various etiologies. As FCM is a nonbiological complex drug and cannot be fully characterized ...
Concentraciones De Hierro En Caña De Azúcar (Saccharum Officinarum L.) Cultivada En Solución Nutritiva
(2016-01-01)
Doubts remain about the adequate iron (Fe) concentration in nutrient solutions used for optimal plant growth, especially in gramineae like sugar cane (Saccharum officinarum L.). Therefore, the aim of this study was to ...
The ferric iron uptake regulator (Fur) from the extreme acidophile Acidithiobacillus ferrooxidans
(SOC GENERAL MICROBIOLOGY, 2005-06)
Acidithiobacillus ferrooxidans is a Gram-negative bacterium that lives at pH 2 in high concentrations of soluble ferrous and ferric iron, making it an interesting model for understanding the biological mechanisms of bacterial ...
The ferric iron uptake regulator (Fur) from the extreme acidophile Acidithiobacillus ferrooxidans
(Microbiology Society, 2005-06)
Acidithiobacillus ferrooxidans is a Gram-negative bacterium that lives at pH 2 in high concentrations of soluble ferrous and ferric iron, making it an interesting model for understanding the biological mechanisms of bacterial ...
Ferric carboxymaltose-mediated attenuation of Doxorubicin-induced cardiotoxicity in an iron deficiency rat model
(Hindawi Publishing Corporation, 2014-04)
Since anthracycline-induced cardiotoxicity (AIC), a complication of anthracycline-based chemotherapies, is thought to involve iron, concerns exist about using iron for anaemia treatment in anthracycline-receiving cancer ...